Patents by Inventor Hiroki Sasaki

Hiroki Sasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11964479
    Abstract: A medium feeding device includes a feeding roller that is provided in a medium feeding path through which a medium is fed and that feeds a medium downstream by rotating in the forward direction in response to power of a motor, a nip roller that is provided in the medium feeding path and that nips a medium in cooperation with the feeding roller and rotates, and a controller configured to control the motor. Based on an increase in a variation value varying in accordance with a drive load of the motor, the controller controls the motor and causes the feeding roller to start a medium feeding operation.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: April 23, 2024
    Assignee: Seiko Epson Corporation
    Inventors: Keisuke Sasaki, Takayuki Tanaka, Hiroki Shinagawa
  • Patent number: 11950480
    Abstract: There are provided a color correction filter for a white organic electroluminescent light source including a resin and 0.1 part by mass or more of a coloring agent having an absorption maximum wavelength in a range of 560 to 620 nm or 460 to 520 nm with respect to 100 parts by mass of the resin, and having a moisture content of 0.5% by mass or less, and an organic EL display device having this filter.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: April 2, 2024
    Assignee: FUJIFILM Corporation
    Inventors: Yu Naito, Nobutaka Fukagawa, Daisuke Sasaki, Hiroki Kuwahara
  • Patent number: 11932006
    Abstract: A recording device includes: a transport unit configured to transport a medium along a transport path, a recording unit configured to perform recording on the medium transported, a wrinkle forming mechanism configured to form wrinkles on a portion of the medium on the transport path before recording is performed, a detection unit configured to detect a state of the wrinkles, and a control unit, wherein the control unit is configured to calculate a rigidity characteristic of the medium based on detection data of the detection unit.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: March 19, 2024
    Assignee: Seiko Epson Corporation
    Inventors: Hiroki Aoki, Tsuneyuki Sasaki
  • Patent number: 11933302
    Abstract: Provided is a rotary compressor excellent in energy saving performance and reliability that can suppress over-compression of a compressed refrigerant compressed in a compression chamber. A rotary compressor includes a discharge port provided on an end plate and partially located outside a cylinder inner wall and a discharge groove provided on the cylinder inner wall and communicating with a compression chamber and the discharge port, the compression chamber compressing a refrigerant by contracting as an annular piston revolves, in which the discharge port faces an end portion of a vane groove on the cylinder inner wall on the compression chamber side.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: March 19, 2024
    Assignee: FUJITSU GENERAL LIMITED
    Inventors: Hideto Uchikai, Motonobu Furukawa, Hiroki Katayama, Takahiro Sasaki
  • Patent number: 11926740
    Abstract: Provided are a resin composition including a compound represented by Formula (1) and a resin, a film and a filter including the resin composition, a liquid crystal display device and a solid-state imaging element including the filter, and a compound suitable as a light absorbing component of the resin composition and the filter. In Formula (1), Dye represents a colorant structural part obtained by removing n1 hydrogen atoms from a squarylium compound having a specific structure. Q1 is a structural part in which energy levels of a highest occupied molecular orbital and a lowest unoccupied molecular orbital satisfy a specific condition. L1 represents a divalent linking group and n1 represents an integer of 1 to 4.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: March 12, 2024
    Assignee: FUJIFILM Corporation
    Inventors: Daisuke Sasaki, Akihiro Hara, Kunihiko Kodama, Nobutaka Fukagawa, Yu Naito, Hiroki Kuwahara
  • Patent number: 11922649
    Abstract: It provides the measurement data of each portion of the target object with a high accuracy. The measurement data calculation apparatus 1020 includes an obtaining unit 1024A, an extraction unit 1024B, a conversion unit 1024C, and a calculation unit 1024D. The obtaining unit 1024A obtains the image data in which the target object is photographed and the full length data of the target object. The extraction unit 1024B extracts the shape data indicating the shape of the target object from the image data. The conversion unit 1024C converts and silhouettes the shape data based on the full length data. The calculation unit 1024D uses the shape data converted by the conversion unit 1024C to calculate the measurement data of each portion of the target object.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: March 5, 2024
    Assignee: Arithmer Inc.
    Inventors: Daisuke Sato, Hiroki Yato, Chikashi Arita, Yoshihisa Ishibashi, Takashi Nakano, Ryosuke Sasaki, Ryosuke Tajima, Yoshihiro Ohta
  • Patent number: 11897954
    Abstract: An objective of the present invention is to provide an anti-TSPAN8/anti-CD3 bispecific antibody and an anti-TSPAN8 antibody usable in treatment or prevention in human. A human monoclonal antibody producing mouse was immunized with a peritoneal disseminated cancer cell isolated from a patient, to obtain an antibody 16B11 and an antibody 16B12 that selectively bind to a peritoneal disseminated cancer cell. These antibodies were anti-TSPAN8 antibodies that bind to the region from amino acid positions 126 to 155 of TSPAN8 and exhibited strong binding activity to TSPAN8 expressed in the peritoneal disseminated cancer cell. Further, an anti-TSPAN8(16B11)-anti-CD3 bispecific antibody produced based on the sequence of 16B11 exhibited a cytotoxic activity against the TSPAN8-expressing cancer cell in vitro, exerted an anti-tumor action on TSPAN8-expressing cancer cell-bearing mice in vivo, and extended the lifetime of peritoneal dissemination model mice.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: February 13, 2024
    Assignees: Astellas Pharma Inc., National Cancer Center
    Inventors: Yoshiyuki Tenda, Masatoshi Yuri, Daisuke Yamajuku, Takeshi Tsutsumi, Yuko Kusuzaki, Hiroki Sasaki, Fumiko Chiwaki, Masayuki Komatsu
  • Publication number: 20230348587
    Abstract: An objective of the present invention is to provide an anti-TSPAN8/anti-CD3 bispecific antibody and an anti-TSPAN8 antibody usable in treatment or prevention in human. A human monoclonal antibody producing mouse was immunized with a peritoneal disseminated cancer cell isolated from a patient, to obtain an antibody 16B11 and an antibody 16B12 that selectively bind to a peritoneal disseminated cancer cell. These antibodies were anti-TSPAN8 antibodies that bind to the region from amino acid positions 126 to 155 of TSPAN8 and exhibited strong binding activity to TSPAN8 expressed in the peritoneal disseminated cancer cell. Further, an anti-TSPAN8(16B11)-anti-CD3 bispecific antibody produced based on the sequence of 16B11 exhibited a cytotoxic activity against the TSPAN8-expressing cancer cell in vitro, exerted an anti-tumor action on TSPAN8-expressing cancer cell-bearing mice in vivo, and extended the lifetime of peritoneal dissemination model mice.
    Type: Application
    Filed: November 15, 2021
    Publication date: November 2, 2023
    Applicants: Astellas Pharma Inc., National Cancer Center
    Inventors: Yoshiyuki TENDA, Masatoshi YURI, Daisuke YAMAJUKU, Takeshi TSUTSUMI, Yuko KUSUZAKI, Hiroki SASAKI, Fumiko CHIWAKI, Masayuki KOMATSU
  • Patent number: 11736830
    Abstract: A solid-state imaging element includes a pixel and an image processing unit. The pixel has a common transistor, a charge accumulation unit, and a power supply. The common transistor has a first terminal and a second terminal. The common transistor maintains a voltage of the first terminal at a predetermined voltage with a voltage applied from the power supply and outputs a voltage corresponding to a change in a voltage of the charge accumulation unit from the second terminal, based on a condition that an element voltage is a ground voltage. The common transistor outputs a voltage corresponding to a change in a voltage of the charge accumulation unit from the first terminal, based on the element voltage is higher than the ground voltage. The image processing unit generates a luminance image according to a change in the voltage output from the second terminal of the common transistor.
    Type: Grant
    Filed: September 28, 2022
    Date of Patent: August 22, 2023
    Assignees: DENSO CORPORATION, TOYOTA JIDOSHA KABUSHIKI KAISHA, MIRISE Technologies Corporation
    Inventor: Hiroki Sasaki
  • Publication number: 20230195019
    Abstract: An image forming apparatus includes a stacking portion including a lifting portion, a feeding member feeding a sheet stacked on the lifting portion to a conveyance passage, a position detector detecting movement of the sheet stacked on to a feedable position to the conveyance passage, a driver including a motor and performing the lifting operation of the lifting portion, a rotation detector detecting rotation of the motor, and a controller. The controller determines a factor that the position detector does not detect the movement of the sheet stacked on the lifting portion to the feedable position within a predetermined time based on a detection result of the rotation detector while controlling the driver to lift up the lifting portion.
    Type: Application
    Filed: December 13, 2022
    Publication date: June 22, 2023
    Inventors: HIROKI SASAKI, YOSHITERU KAIDA
  • Publication number: 20230106422
    Abstract: A solid-state imaging element includes a pixel and an image processing unit. The pixel has a common transistor, a charge accumulation unit, and a power supply. The common transistor has a first terminal and a second terminal. The common transistor maintains a voltage of the first terminal at a predetermined voltage with a voltage applied from the power supply and outputs a voltage corresponding to a change in a voltage of the charge accumulation unit from the second terminal, based on a condition that an element voltage is a ground voltage. The common transistor outputs a voltage corresponding to a change in a voltage of the charge accumulation unit from the first terminal, based on the element voltage is higher than the ground voltage. The image processing unit generates a luminance image according to a change in the voltage output from the second terminal of the common transistor.
    Type: Application
    Filed: September 28, 2022
    Publication date: April 6, 2023
    Inventor: HIROKI SASAKI
  • Publication number: 20220087987
    Abstract: The present invention provides a method for treating SWI/SNF complex-deficient cancers comprising a glutathione (GSH) metabolic pathway inhibitor, a pharmaceutical composition comprising a glutathione (GSH) metabolic pathway inhibitor for therapy in SWI/SNF complex-deficient cancers, and a glutathione (GSH) metabolic pathway inhibitor for use in treating SWI/SNF complex-deficient cancers. The present invention also provides a method for detecting and/or selecting a susceptible patient to a glutathione (GSH) metabolic pathway inhibitor.
    Type: Application
    Filed: December 16, 2019
    Publication date: March 24, 2022
    Applicants: National Cancer Center, ONO PHARMACEUTICAL CO., LTD.
    Inventors: Hideaki OGIWARA, Takashi KOHNO, Hiroki SASAKI
  • Publication number: 20210399034
    Abstract: A camera module is configured to capture an optical image of a target area and includes a lens member, an imager, a light transmitting member, and a seat. The lens member is configured to receive light from the target area. The imager has a curved portion convex in a direction away from the lens member and is configured to capture the optical image formed on the curved portion. The light transmitting member optically couples the lens member and the imager. The seat has a supporting portion that supports an outer rim of the imager and a fluid space defined inside the supporting portion. A heat dissipation fluid undergoes convection in the fluid space. The curved portion is interposed between the light transmitting member and the seat having the supporting portion and the fluid space.
    Type: Application
    Filed: June 16, 2021
    Publication date: December 23, 2021
    Inventors: Kouji SATOU, Hiroki SASAKI, Shotaro MIYAWAKI, Akira WADA, Satoru WAKIYAMA, Kazuhiro AOYAMA
  • Publication number: 20210292853
    Abstract: The purpose is to reveal a polynucleotide that is a novel causal gene of pancreatic cancer and thereby provide a method for detecting the polynucleotide or a polypeptide encoded thereby to select a subject positive for the polynucleotide or polypeptide and a method expected to be useful for to identify patients suitable for therapies and a primer set therefor and a kit for detection. In the method, a polynucleotide comprising a fusion point of a part of a CLDN18 gene and an ARHGAP6 gene or a polynucleotide comprising a fusion point of a part of a CLDN18 gene and an ARHGAP26 gene, or a fusion protein encoded thereby is detected. The primer set comprises a sense primer designed for a part encoding CLDN18 and an antisense primer designed for a part encoding ARHGAP6 or a part encoding ARHGAP26.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 23, 2021
    Applicants: Astellas Pharma Inc., National Cancer Center
    Inventor: Hiroki SASAKI
  • Patent number: 11053553
    Abstract: The purpose is to reveal a polynucleotide that is a novel causal gene of pancreatic cancer and thereby provide a method for detecting the polynucleotide or a polypeptide encoded thereby to select a subject positive for the polynucleotide or polypeptide and a method expected to be useful for to identify patients suitable for therapies and a primer set therefor and a kit for detection. In the method, a polynucleotide comprising a fusion point of a part of a CLDN18 gene and an ARHGAP6 gene or a polynucleotide comprising a fusion point of a part of a CLDN18 gene and an ARHGAP26 gene, or a fusion protein encoded thereby is detected. The primer set comprises a sense primer designed for a part encoding CLDN18 and an antisense primer designed for a part encoding ARHGAP6 or a part encoding ARHGAP26.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: July 6, 2021
    Assignees: Astellas Pharma Inc., National Cancer Center
    Inventor: Hiroki Sasaki
  • Patent number: 10969390
    Abstract: A method for evaluating an efficacy of a chemoradiotherapy against squamous cell carcinoma comprises the following steps (a) to (c): (a) detecting an expression level of at least one gene selected from a SIM2 gene and genes co-expressed with the SIM2 gene in a squamous cell carcinoma specimen isolated from a subject; (b) comparing the expression level detected in the step (a) with a reference expression level of the corresponding gene; and (c) determining that an efficacy of a chemoradiotherapy against squamous cell carcinoma in the subject is high if the expression level in the subject is higher than the reference expression level as a result of the comparison in the step (b).
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: April 6, 2021
    Assignees: NATIONAL CANCER CENTER, KYOTO UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Hiroki Sasaki, Kazuhiko Aoyagi, Manabu Muto, Hiroo Takahashi
  • Patent number: 10903228
    Abstract: A semiconductor storage device includes a semiconductor substrate and a plurality of first wiring layers stacked above the semiconductor substrate in a first direction orthogonal to the semiconductor substrate, and extending in a second direction intersecting the first direction and parallel to the semiconductor substrate. The device further includes a first memory pillar including a semiconductor layer and a first insulation layer extending in the first direction, the first insulation layer provided between the plurality of first wiring layers and the semiconductor layer so as to contact the semiconductor layer, and charge storage layers provided respectively between the plurality of first wiring layers and the first insulation layer. One or more of the charge storage layers is in contact with the first insulation layer. A plurality of second insulation layers is provided between each of the plurality of first wiring layers and each of the charge storage layers.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: January 26, 2021
    Assignee: TOSHIBA MEMORY CORPORATION
    Inventors: Hiroki Sasaki, Atsushi Murakoshi, Ryuji Ohba
  • Publication number: 20200385779
    Abstract: The object of the invention is to elucidate a new causative gene of cancer, polynucleotide, and thereby provide a method for detecting the polynucleotide or a polypeptide that is encoded by the polynucleotide, as well as a primer set or a detection kit for such detection. The detection method detects a fusion gene of a part of an OCLN gene and a part of an ARHGAP26 gene, or a fusion protein encoded by such gene. The primer set includes a sense primer designed from a section encoding OCLN and an antisense primer designed from a section encoding ARHGAP26.
    Type: Application
    Filed: March 13, 2020
    Publication date: December 10, 2020
    Inventors: Hiroki Sasaki, Hitoshi Ichikawa, Makoto Asaumi, Kazuhisa Tsunoyama
  • Patent number: 10818688
    Abstract: A storage device includes: a plurality of electrode films stacked in a first direction, and extending in a second direction intersecting the first direction; a first semiconductor film provided adjacent to the plurality of electrode films, and extending in the first direction; a first charge holding film provided between one electrode film among the plurality of electrode films, and the semiconductor film, and including any one of a metal, a metal compound, and a high dielectric material; and a second semiconductor film located between the first semiconductor film and the charge holding film, and extending in the first direction along the first semiconductor film. The second semiconductor film is electrically insulated from the plurality of electrode films, the first charge holding film, and the first semiconductor film.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: October 27, 2020
    Assignee: TOSHIBA MEMORY CORPORATION
    Inventors: Atsushi Murakoshi, Hiroki Sasaki
  • Publication number: 20200299782
    Abstract: The object of the invention is to elucidate a new causative gene of cancer, polynucleotide, and thereby provide a method for detecting the polynucleotide or a polypeptide that is encoded by the polynucleotide, as well as a primer set or a detection kit for such detection. The detection method detects a fusion gene of a part of an RP2 gene and a part of an ARHGAP6 gene, or a fusion protein encoded by such gene. The primer set includes a sense primer designed from a section encoding RP2 and an antisense primer designed from a section encoding ARHGAP6.
    Type: Application
    Filed: March 13, 2020
    Publication date: September 24, 2020
    Inventors: Hiroki Sasaki, Hitoshi Ichikawa